You have 9 free searches left this month | for more free features.

City

Overall Status

Not yet recruiting (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

Masonic Cancer Center, University of Minnesota (1)

Collaborator

Intervention

busulfan (1)

fludarabine (1)

levetiracetam (1)

melphalan (1)

rituximab (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Other (1)

Study Type

Interventional (1)

GFSR

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Hematologic Malignancy, Acute Leukemia, Remission Trial (Fludarabine, Busulfan, Melphalan)

Not yet recruiting

Hematologic Malignancy
+21 more

Fludarabine
+4 more

(no location specified)

Feb 9, 2023